Results 11 to 20 of about 7,054 (204)

Surgical treatment for high-grade pseudomyxoma peritonei originated from appendix: Analysis of clinical outcomes of repeated debulking surgery [PDF]

Korean Journal of Clinical Oncology, 2016
Purpose To evaluate the effect of repeated debulking surgery for high-grade pseudomyxoma peritonei (PMP) originating from the appendix. Methods Between January 1998 and December 2014, fifty patients, who underwent debulking surgery for high-grade PMP ...
Jung Hyun Park, Inho Song, Dong Woon Lee, Yoon-Hye Kwon, Jeong-Ki Kim, Sang Hui Moon, Ji Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park   +9 more
doaj   +1 more source

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

World Journal of Surgical Oncology, 2020
Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Juan José Segura-Sampedro, Rafael Morales-Soriano, Álvaro Arjona-Sánchez, Pedro Cascales-Campos   +3 more
doaj   +1 more source

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]

, 2015
Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim, Liberale, Gabriel, Van Der Speeten, Kurt, Willaert, Wouter   +3 more
core   +4 more sources

Impact of proper surgical treatment on the survival of patients with epithelial ovary cancer

Revista do Colégio Brasileiro de Cirurgiões, 2022
Objective: to evaluate the quality of surgical treatment of ovarian cancer patients and assess the impact of adequate surgical oncological treatment on disease-free survival and overall survival of patients with advanced epithelial ovarian cancer ...
FLAVIO HENRIQUE FARIA, ANA PAULA DRUMMOND LAGE, ANGÉLICA NOGUEIRA RODRIGUES, ALBERTO JULIUS ALVES WAINSTEIN   +3 more
doaj   +2 more sources

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Revista do Colégio Brasileiro de Cirurgiões, 2023
Peritoneal carcinomatosis (PC) indicates advanced stage cancer, which is generally associated with a poor outcome and a 6 to 12 months. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an option for treating patients ...
JAIRO SEBASTIÁN ASTUDILLO VALLEJO, FABIO LOPES DE QUEIROZ, ANTÔNIO LACERDA FILHO, PAULO ROCHA FRANÇA NETO, BRENO XAIA MARTINS DA COSTA, RODRIGO ALMEIDA PAIVA, SILVÉRIO LEONARDO MACEDO GARCIA, SERGIO BOTREL SILVA   +7 more
doaj   +2 more sources

Trends in extent of surgical cytoreduction for patients with ovarian cancer.

PLoS ONE, 2021
PurposeTo identify patient and hospital characteristics associated with extended surgical cytoreduction in the treatment of ovarian cancer.MethodsA retrospective analysis using the National Inpatient Sample (NIS) database identified women hospitalized ...
Deanna H Wong, Alexandra L Mardock, Erica N Manrriquez, Tiffany S Lai, Yas Sanaiha, Abdulrahman K Sinno, Peyman Benharash, Joshua G Cohen   +7 more
doaj   +3 more sources

Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population

Oman Medical Journal, 2015
Objective: The aim of this study was to evaluate the role of secondary cytoreductive surgery in Asian patients with recurrent ovarian cancer and to assess prognostic variables on overall post-recurrence survival time.
Rani Akhil Bhat, Yin Nin Chia, Yong Kuei Lim, Kwai Lam Yam, Cindy Lim, Melissa Teo   +5 more
doaj   +1 more source

Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/Hipec) from a Tertiary Cancer Center in India [PDF]

Journal of Clinical and Diagnostic Research, 2015
Background: Peritoneal carcinomatosis (PC) can arise directly from peritoneum (primary) or from regional spread of gastrointestinal and gynecological malignancies. It is often considered a terminal event.
Naveen Padmanabhan, Barath Raj Kumar, Ansar Pullampara Pookunju, Ayyapan Srinivasan, Vikash Mahajan   +4 more
doaj   +1 more source

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer [PDF]

, 2017
Background: More information is needed for selection of patients with peritoneal metastases from endometrial cancer (EC) to undergo cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: This study analyzed clinical,
Biacchi, Daniele, Christopoulou, Athina, Ciardi, Antonio, Cornali, Tommaso, Efstathiou, Elias, Framarino dei Malatesta, Marialuisa, Kopanakis, Nikolaos, Sammartino, Paolo, Spagnoli, Alessandra, Spiliotis, John   +9 more
core   +1 more source

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

BMC Cancer, 2017
Background This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). Methods Patients
Kyung Jin Eoh, Jung Won Yoon, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim   +6 more
doaj   +1 more source